Paganini Biopharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Paganini Biopharma General Information

Description

Provider of therapeutics for cancer treatment. The company's therapeutics for cancer treatment include development of anti-epithelial membrane protein 2 (EMP2) fully human monoclonal antibody, ONCR-201 to treat tumors, enabling patients to get treated against breast cancer including triple negative, ovarian cancer and endometrial cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 17328 Ventura Boulevard
  • Suite 147
  • Encino, CA 91316
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 17328 Ventura Boulevard
  • Suite 147
  • Encino, CA 91316
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paganini Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Paganini Biopharma‘s full profile, request access.

Request a free trial

Paganini Biopharma Patents

Paganini Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013203396-A1 Anti-emp2 therapy reduces cancer stem cells Active 30-Mar-2012
AU-2013203396-B2 Anti-emp2 therapy reduces cancer stem cells Inactive 30-Mar-2012
AU-2013203396-C1 Anti-emp2 therapy reduces cancer stem cells Inactive 30-Mar-2012
CA-2868791-A1 Anti-emp2 therapy reduces cancer stem cells Inactive 30-Mar-2012
EP-2831110-A1 Anti-emp2 therapy reduces cancer stem cells Active 30-Mar-2012 C07K16/18
To view Paganini Biopharma’s complete patent history, request access »

Paganini Biopharma FAQs

  • When was Paganini Biopharma founded?

    Paganini Biopharma was founded in 2013.

  • Where is Paganini Biopharma headquartered?

    Paganini Biopharma is headquartered in Encino, CA.

  • What industry is Paganini Biopharma in?

    Paganini Biopharma’s primary industry is Buildings and Property.

  • Is Paganini Biopharma a private or public company?

    Paganini Biopharma is a Private company.

  • What is Paganini Biopharma’s current revenue?

    The current revenue for Paganini Biopharma is .

  • When was Paganini Biopharma acquired?

    Paganini Biopharma was acquired on 07-Nov-2017.

  • Who acquired Paganini Biopharma?

    Paganini Biopharma was acquired by OncoResponse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process